Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: LOR who wrote (7971)	10/31/2005 10:04:29 AM
From: grounded	Read Replies (1) \| Respond to of 8117

NEWS ____________________________________________________ Pyng to study F.A.S.T.1 at Cincinnati Children's 2005-10-31 09:47 ET - News Release Mr. Michael Jacobs reports PYNG MEDICAL CORP. AND CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTRE SIGN DEVELOPMENT AGREEMENT Pyng Medical Corp. and Cincinnati Children's Hospital Medical Centre have entered a letter of commitment on Oct. 18, 2005, on a collaborative effort to study the feasibility of using the F.A.S.T.1 System in preadolescent and adolescent patients. The F.A.S.T.1 System is an alternative to conventional intravenous (IV) infusion that allows emergency medical technicians (EMTs) and doctors to achieve faster, safer and more reliable vascular access for fluid resuscitation in shock and trauma victims. The system has not yet been tested or approved for use in children. Pyng Medical has entered into this formal agreement with Cincinnati Children's, one of the leading pediatric medical centres in the United States, to cover a two-phase collaborative study to initially assess adolescent manubrium physiology, through the vast data bank of the Cincinnati Children's radiology department, and to determine any design, engineering and functional requirements that might be needed to the current F.A.S.T.1 System to meet the target patient group through a clinical trial. ______________________________________ I believe that this news confirms that the FAST1 is the preffered leader and the product to emulate...